Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 24, 2017

DrugPatentWatch Database Preview

Dicyclomine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for dicyclomine hydrochloride and what is the scope of freedom to operate?

Dicyclomine hydrochloride
is the generic ingredient in four branded drugs marketed by Sun Pharm Inds, Hikma Pharms Llc, Forest Labs Inc, Watson Labs, Mylan, Lannett, Luitpold Pharms Inc, Pioneer Pharms, Aptalis Pharma Us, West-ward Pharms Int, Mikart, and Alpharma Us Pharms, and is included in twenty-two NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for dicyclomine hydrochloride. Forty-five suppliers are listed for this compound.

Summary for Generic Name: dicyclomine hydrochloride

Drug Master File Entries: see list4
Suppliers / Packagers: see list45
Bulk Api Vendors: see list24
Clinical Trials: see list988
Patent Applications: see list974
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:dicyclomine hydrochloride at DailyMed

Pharmacology for Ingredient: dicyclomine hydrochloride

Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
dicyclomine hydrochloride
CAPSULE;ORAL083179-001Feb 12, 1986DISCNNoNo► Subscribe► Subscribe
dicyclomine hydrochloride
TABLET;ORAL040230-001Feb 26, 1999ABRXNoNo► Subscribe► Subscribe
Hikma Pharms Llc
dicyclomine hydrochloride
TABLET;ORAL040161-001Oct 1, 1996DISCNNoNo► Subscribe► Subscribe
dicyclomine hydrochloride
CAPSULE;ORAL040319-001Sep 7, 1999ABRXNoNo► Subscribe► Subscribe
Aptalis Pharma Us
dicyclomine hydrochloride
SYRUP;ORAL007961-002Oct 15, 1984DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Formulary management
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus